𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy

✍ Scribed by Karpman, D.; Tati, R.; Kristoffersson, A.-C.; Ståhl, A.-L.; Rebetz, J.; Wang, L.; Licht, C.; Motto, D.

Book ID
121779730
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
67 KB
Volume
56
Category
Article
ISSN
0161-5890

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ADAMTS13 activity levels in patients wit
ADAMTS13 activity levels in patients with human immunodeficiency virus-associated thrombotic microangiopathy and profound CD4 deficiency
✍ Yara A. Park; Shauna N. Hay; Mark E. Brecher 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Background: Thrombotic microangiopathy (TMA) encompasses a number of disorders with hemolytic anemia and thrombocytopenia, including thrombotic thrombocytopenic purpura (TTP). A deficiency in ADAMTS13 enzyme levels, along with an inhibitory antibody, is found in most patients with i

Hematocrit and C-reactive protein predic
Hematocrit and C-reactive protein predict treatment response times in ADAMTS13-deficient thrombotic microangiopathy
✍ Noelle I. Samia; Kenneth D. Friedman; Jerome L. Gottschall; Thomas J. Raife 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

## Abstract Thrombotic microangiopathy (TMA) syndromes are a heterogeneous group of microvascular syndromes that are typically treated with plasma exchange and other adjunctive therapies. Important pathogenic factors, such as ADAMTS13 deficiency, define distinct subsets of TMA. New treatments for T